UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Development of a clinical risk score to predict death in patients with COVID‐19

Diabetes/metabolism research and reviews, 2022-07, Vol.38 (5), p.e3526-n/a

2022

Volltextzugriff (PDF)

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

European radiology, 2020-12, Vol.30 (12), p.6808-6817

2020

Volltextzugriff (PDF)

Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV

Viruses, 2022-06, Vol.14 (6), p.1339

2022

Volltextzugriff (PDF)

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.211-213.e4

2020

Volltextzugriff (PDF)

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience

International journal of antimicrobial agents, 2019-04, Vol.53 (4), p.408-415

2019

Volltextzugriff (PDF)

Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

Nutrition, metabolism, and cardiovascular diseases, 2020-10, Vol.30 (11), p.1899-1913

2020

Volltextzugriff (PDF)

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

The Lancet (British edition), 2018-06, Vol.391 (10138), p.2417-2429

2018

Volltextzugriff (PDF)

Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy

Radiologia medica, 2021-09, Vol.126 (9), p.1170-1180

2021

Volltextzugriff (PDF)

The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review

International journal of molecular sciences, 2022-01, Vol.23 (2), p.803

2022

Volltextzugriff (PDF)

Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1799-1801

2020

Volltextzugriff (PDF)

Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia

Biomolecules (Basel, Switzerland), 2023-06, Vol.13 (7), p.1040

2023

Volltextzugriff (PDF)

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

European journal of internal medicine, 2020-12, Vol.82, p.38-47

2020

Volltextzugriff (PDF)

A Unified Model for the Optimal Management of Electrical and Thermal Equipment of a Prosumer in a DR Environment

IEEE transactions on smart grid, 2019-03, Vol.10 (2), p.1791-1800

2019

Volltextzugriff (PDF)

Pillars of long-term antiretroviral therapy success

Pharmacological research, 2023-10, Vol.196, p.106898-106898, Article 106898

2023

Volltextzugriff (PDF)

A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection

Journal of viral hepatitis, 2019-07, Vol.26 (7), p.846-855

2019

Volltextzugriff (PDF)

Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2870

2020

Volltextzugriff (PDF)

Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

HIV medicine, 2021-10, Vol.22 (9), p.843-853

2021

Volltextzugriff (PDF)

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience

International journal of antimicrobial agents, 2024-07, Vol.64 (1), p.107190, Article 107190

2024

Volltextzugriff (PDF)

RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

Vascular pharmacology, 2020-12, Vol.135, p.106805-106805, Article 106805

2020

Volltextzugriff (PDF)

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience

International journal of antimicrobial agents, 2024-04, p.107190, Article 107190

2024

Volltextzugriff (PDF)

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Journal of hepatology, 2021-02, Vol.74 (2), p.340-349

2021

Volltextzugriff (PDF)

Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up

International journal of cardiology, 2021-09, Vol.339, p.235-242

2021

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(62)
Humans
(48)
Male
(32)
Female
(30)
Middle Aged
(29)
Infectious Diseases
(27)
Adult
(23)
Covid-19
(22)
Aged
(16)
Infections
(16)
Microbiology
(14)
Mortality
(13)
Patients
(13)
Severe Acute Respiratory Syndrome Coronavirus 2
(13)
Sars-Cov-2
(12)
Hiv
(11)
Hiv Infections - Drug Therapy
(11)
Hospitals
(10)
Human Immunodeficiency Virus
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a clinical risk score to predict death in patients with COVID‐19

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience

Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Tocilizumab effects in COVID-19 pneumonia: role of CT texture analysis in quantitative assessment of response to therapy

The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression

Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa

Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

A Unified Model for the Optimal Management of Electrical and Thermal Equipment of a Prosumer in a DR Environment

Pillars of long-term antiretroviral therapy success

A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection

Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study

Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience

RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis

Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up

Suchergebnisse filtern